100 related articles for article (PubMed ID: 33511895)
21. Trends in Spinal Orthosis Utilization Among Patients Insured through Medicare Part B.
Dholaria N; Bauer I; Kelbert J; Barbagli G; Pico A; Deaver C; Quiceno E; Nosova K; Hussein A; Mayeku J; Soto Rubio DT; Alhalal IA; Heinzmann E; Pacheco N; Al-Arfaj A; Li C; Prim M; Baaj A
Spine (Phila Pa 1976); 2023 Nov; ():. PubMed ID: 37970709
[TBL] [Abstract][Full Text] [Related]
22. Potential Cost Savings in Medicare Part D Across Gastroenterology: An Assessment of Alternative Drug Sourcing.
Bouvette CA; Bouvette M; Yohannan B; Rumman A; Ali I
Am J Gastroenterol; 2024 Apr; 119(4):764-767. PubMed ID: 38084855
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Nail Excision Practice Patterns in the Medicare Provider Utilization and Payment Database 2012-2017.
Hill RC; Wang Y; Vlahovic T; Lipner SR
Cutis; 2024 Jan; 113(1):E22-E25. PubMed ID: 38478930
[No Abstract] [Full Text] [Related]
24. Health care provider movement increased through COVID-19.
Luo Q; Park YH; Chen C; Petterson S
Health Aff Sch; 2024 Jun; 2(6):qxae065. PubMed ID: 38841718
[TBL] [Abstract][Full Text] [Related]
25. When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
Gracies JM; Jech R; Valkovic P; Marque P; Vecchio M; Denes Z; Vilain C; Delafont B; Picaut P
Brain Commun; 2021; 3(1):fcaa201. PubMed ID: 33543139
[TBL] [Abstract][Full Text] [Related]
26. Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.
Diniz de Lima F; Faber I; Servelhere KR; Bittar MFR; Martinez ARM; Piovesana LG; Martins MP; Martins CR; Benaglia T; de Sá Carvalho B; Nucci A; França MC
Mov Disord; 2021 Jul; 36(7):1654-1663. PubMed ID: 33595142
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin dosing in arm muscles: contextual factors.
Dressler D; Kopp B; Adib Saberi F
J Neural Transm (Vienna); 2021 Mar; 128(3):315-319. PubMed ID: 33515332
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
J Rehabil Med; 2021 Feb; 53(2):jrm00157. PubMed ID: 33616192
[TBL] [Abstract][Full Text] [Related]
29. The whole truth about botulinum toxin - a review.
Witmanowski H; Błochowiak K
Postepy Dermatol Alergol; 2020 Dec; 37(6):853-861. PubMed ID: 33603602
[TBL] [Abstract][Full Text] [Related]
30. Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program.
Cohen JL; Green LJ; Beer KR; Liu Y; Gallagher CJ
Dermatol Surg; 2021 Apr; 47(4):511-515. PubMed ID: 33587381
[TBL] [Abstract][Full Text] [Related]
31. Use of Botulinum Toxin A to Treat Chemotherapy-Induced Raynaud's Phenomenon.
Potluri TK; Lee FG; Song E; Wallace SJ; Miller N
Cureus; 2021 Jan; 13(1):e12511. PubMed ID: 33564517
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity to Botulinum Toxin Type A: A Systematic Review With Meta-Analysis Across Therapeutic Indications.
Rahman E; Alhitmi HK; Mosahebi A
Aesthet Surg J; 2022 Jan; 42(1):106-120. PubMed ID: 33528495
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin A improves psychological distress in patients with hemifacial spasm.
Wang C; Zhu X; Xia L; Xie P; Tian X; Shang J; Han Q
Acta Neurol Belg; 2022 Feb; 122(1):43-49. PubMed ID: 33515182
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic regimen and route of administration do not alter rates of urinary tract infection after intravesical botulinum toxin injection for overactive bladder.
Eckhardt SE; Takashima Y; Handler SJ; Tenggardjaja C; Yazdany T
Int Urogynecol J; 2022 Mar; 33(3):703-709. PubMed ID: 33594517
[TBL] [Abstract][Full Text] [Related]
35. Highly Selective Partial Neurectomy for Lower-Extremity Spasticity: 2-Dimensional Operative Video.
Abou-Al-Shaar H; Mahan MA
Oper Neurosurg (Hagerstown); 2021 May; 20(6):E442-E443. PubMed ID: 33582808
[TBL] [Abstract][Full Text] [Related]
36. Assessments and Interventions for Spasticity in Infants With or at High Risk for Cerebral Palsy: A Systematic Review.
Ayala L; Winter S; Byrne R; Fehlings D; Gehred A; Letzkus L; Noritz G; Paton MCB; Pietruszewski L; Rosenberg N; Tanner K; Vargus-Adams J; Novak I; Maitre NL
Pediatr Neurol; 2021 May; 118():72-90. PubMed ID: 33563492
[TBL] [Abstract][Full Text] [Related]
37. Reliability and Validity of the Modified Heckmatt Scale in Evaluating Muscle Changes With Ultrasound in Spasticity.
Moreta MC; Fleet A; Reebye R; McKernan G; Berger M; Farag J; Munin MC
Arch Rehabil Res Clin Transl; 2020 Dec; 2(4):100071. PubMed ID: 33543098
[TBL] [Abstract][Full Text] [Related]
38. Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines.
Siddiqui M; Shah PV; Balani P; Lopez AR; Nobleza CMN; Khan S
Cureus; 2021 Jan; 13(1):e13002. PubMed ID: 33542885
[TBL] [Abstract][Full Text] [Related]
39. "Millennial Botulinum Toxin": A Retrospective Age-Matched Cohort Study With OnabotulinumtoxinA.
Chung K; Orme N; Sherber N
Dermatol Surg; 2021 Jun; 47(6):882-884. PubMed ID: 33625149
[No Abstract] [Full Text] [Related]
40. Treatment outcomes of overactive bladder with combined therapies of botulinum toxin injections and oral agents.
Woll A; Edenfield A; Locke M; Swift S
Int Urogynecol J; 2021 Oct; 32(10):2803-2806. PubMed ID: 33620537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
